The Dutch medtech said the panel, which covers 21 viral and bacterial targets, had been previously authorized under an FDA Emergency Use Authorization as the QIAstat-Dx Respiratory SARS-CoV-2 Panel.

With new SARS-CoV-2 variants of concern emerging globally, implementing effective public health measures is truly a race against time. Rapid, high-throughput NGS can provide real-time insights into ...

Combatting the COVID-19 pandemic requires greater insights into the molecular epidemiology of SARS-CoV-2 to trace existing outbreaks, study viral evolution and advance vaccine and drug development ...